Banco Bilbao Vizcaya Argentaria S.A. Sells 6,651 Shares of Cardinal Health, Inc. $CAH

Key Points

• Banco Bilbao Vizcaya Argentaria S.A. reduced its holdings in Cardinal Health, Inc. by 28.1%, ending the quarter with 17,003 shares valued at $2,340,000.
• CEO Jason M. Hollar and insider Ola M. Snow both sold significant shares of Cardinal Health, with Hollar's transaction totaling over $16 million.
• Despite recent insider sales, twelve analysts have rated Cardinal Health as a "Buy," with an average price target of $163.20.

Banco Bilbao Vizcaya Argentaria S.A. lessened its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 28.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,003 shares of the company's stock after selling 6,651 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Cardinal Health were worth $2,340,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Groupama Asset Managment raised its stake in shares of Cardinal Health by 7.7% during the first quarter. Groupama Asset Managment now owns 12,304 shares of the company's stock valued at $1,679,000 after purchasing an additional 877 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S raised its holdings in Cardinal Health by 102.7% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 183,175 shares of the company's stock worth $25,236,000 after buying an additional 92,795 shares during the period. Quantbot Technologies LP raised its holdings in Cardinal Health by 19.8% during the 1st quarter. Quantbot Technologies LP now owns 91,613 shares of the company's stock worth $12,622,000 after buying an additional 15,168 shares during the period. Wellington Management Group LLP raised its holdings in Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock worth $328,470,000 after buying an additional 2,249,241 shares during the period. Finally, Cornerstone Select Advisors LLC raised its holdings in Cardinal Health by 6.2% during the 1st quarter. Cornerstone Select Advisors LLC now owns 12,803 shares of the company's stock worth $1,764,000 after buying an additional 748 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Down 2.3%

Shares of CAH stock traded down $3.5270 during trading hours on Friday, reaching $148.0430. 2,685,985 shares of the company's stock were exchanged, compared to its average volume of 2,600,685. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44. The stock has a market capitalization of $35.35 billion, a P/E ratio of 22.95, a P/E/G ratio of 1.25 and a beta of 0.67. The business has a fifty day moving average price of $159.02 and a 200-day moving average price of $145.58.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. During the same period in the previous year, the company earned $1.84 earnings per share. The company's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is presently 31.63%.

Insider Activity at Cardinal Health

In other news, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares in the company, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.09% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Morgan Stanley reaffirmed an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Bank of America lifted their target price on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Evercore ISI lowered their target price on Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research note on Tuesday, August 12th. Finally, Leerink Partners lowered their target price on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and an average price target of $163.20.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.